Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov 10:2:56.
doi: 10.3389/fphar.2011.00056. eCollection 2011.

MEGen: A Physiologically Based Pharmacokinetic Model Generator

Affiliations
Free PMC article

MEGen: A Physiologically Based Pharmacokinetic Model Generator

George Loizou et al. Front Pharmacol. .
Free PMC article

Abstract

Physiologically based pharmacokinetic models are being used in an increasing number of different areas. However, they are perceived as complex, data hungry, resource intensive, and time consuming. In addition, model validation and verification are hindered by the relative complexity of the equations. To begin to address these issues a web application called MEGen for the rapid construction and documentation of bespoke deterministic PBPK model code is under development. MEGen comprises a parameter database and a model code generator that produces code for use in several commercial software packages and one that is freely available. Here we present an overview of the current capabilities of MEGen, and discuss future developments.

Keywords: database; equation; generator; pharmacokinetic; physiologically based.

PubMed Disclaimer

Figures

Figure 1
Figure 1
MEGen components and outputs.
Figure 2
Figure 2
Database search page showing details of a selected parameter.
Figure 3
Figure 3
Database search page: application of filters.
Figure 4
Figure 4
Initial configuration page.
Figure 5
Figure 5
Configuration pages: selection of, (A) animal, (B) chemical, and (C) compartments.
Figure 6
Figure 6
Configuration page: selection of optional parts of model.
Figure 7
Figure 7
Parameter selection using the Caddy.
Figure 8
Figure 8
Auto-population of model using the Caddy editor.
Figure 9
Figure 9
Model review page.
Figure 10
Figure 10
Generate code page.
Figure 11
Figure 11
A conceptual view of the data schema showing the hierarchical arrangement of parameter groupings.
Figure 12
Figure 12
Mass-balance check functions: quotient, dose against mass, and mass/dose quotient against time plot for the vinyl chloride model exported and visualized in acslX Libero.
Figure 13
Figure 13
Reproduction of Figure 2A from Himmelstein et al. (2004). In vivo closed-chamber gas uptake of β-chloroprene in the B6C3F1 mouse. Mean experimental data (symbols) and simulations (lines) represent initial concentrations of 2, 10, 50 270, or 363 ppm. PBPK model exported in Berkeley Madonna syntax.
Figure 14
Figure 14
Reproduction of Figure 5 from Clewell et al. (2001). Simulations (lines) and experimentally determined (symbols) glutathione concentrations (as percent of control animal levels) at 0, 20, and 44 h following 4-h inhalation exposures to VC at formula image5760, formula image192, formula image57.6, formula image19.2, and formula image5.76 ppm. PBPK model exported in acslX Libero version 3.0.1.6.
Figure 15
Figure 15
Reproduction of Figure 5 from Loizou and Spendiff (2004). Simulated (line) versus measured (symbols) blood ethanol concentrations following intra-venous administration of 0.4 g kg−1 ethanol for 1 h. PBPK model exported in MATLAB version R2010b.

Similar articles

Cited by

References

    1. Baldrick P. (2003). Toxicokinetics in preclinical evaluation. Drug Discov. Today 8, 127–13310.1016/S1359-6446(02)02568-0 - DOI - PubMed
    1. Barton H. A., Chiu W. A., Setzer R. W., Andersen M. E., Bailer A. J., Bois F. Y., Dewoskin R. S., Hays S., Johanson G., Jones N., Loizou G., Macphail R. C., Portier C. J., Spendiff M., Tan Y. M. (2007). Characterizing uncertainty and variability in physiologically-based pharmacokinetic (PBPK) models: state of the science and needs for research and implementation. Toxicol. Sci. 99, 395–40210.1093/toxsci/kfm100 - DOI - PubMed
    1. Brown R. P., Delp M. D., Lindstedt S. L., Rhomberg L. R., Beliles R. P. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol. Ind. Health 13, 407–484 - PubMed
    1. Chiu W. A., Barton H. A., Dewoskin R. S., Schlosser P., Thompson C. M., Sonawane B., Lipscomb J. C., Krishnan K. (2007). Evaluation of physiologically based pharmacokinetic models for use in risk assessment. J. Appl. Toxicol. 27, 218–23710.1002/jat.1225 - DOI - PubMed
    1. Clark L. H., Setzer R. W., Barton H. A. (2004). Framework for evaluation of physiologically-based pharmacokinetic models for use in safety or risk assessment. Risk Anal. 24, 1697–171710.1111/j.0272-4332.2004.00561.x - DOI - PubMed

LinkOut - more resources